Yahoo Malaysia Web Search

Search results

  1. Heather Bresch (née Manchin; born June 27, 1969) is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. Bresch retired in 2020, upon the closing of Mylan’s combination with Upjohn.

  2. Sep 7, 2021 · Heather Bresch, the former CEO of Mylan and the daughter of Sen. Joe Manchin, colluded with Pfizer to eliminate its EpiPen competitor and raise prices. She also approved a scheme to force customers to buy two EpiPens at once, regardless of medical need.

  3. Jul 29, 2019 · Bresch has led Mylan since 2012, overseeing its growth from a generics company to a global healthcare giant. She will step down in mid-2020, after the deal with Pfizer's Upjohn business, following years of controversies and investigations.

  4. Oct 20, 2021 · As if his own record weren’t bad enough, former coal baron and current West Virginia senator Joe Manchin’s daughter Heather Bresch — who doubles as a major donor to Joe — is a price-gouging drug profiteer who has played a central role in her father’s destructive political career.

  5. Jan 27, 2017 · In her first in-depth interview since testifying on Capitol Hill, Bresch defends Mylan's investment in EpiPen and blames the system for high drug prices. She says she agrees with President Trump's demand for change and wants to work with employers, patients and the administration to fix the problem.

  6. Mar 17, 2022 · Heather Bresch, the former CEO of Mylan and daughter of Sen. Joe Manchin, faces antitrust lawsuits over the price hikes of EpiPens. The article exposes how Bresch shut down a union plant in West Virginia and fabricated her MBA degree.

  7. Aug 24, 2016 · Heather Bresch's career has risen along with her father's, a fact that has not gone unnoticed by her critics. But Bresch's corporate rise is also a modern-day success story.